GILBOA THERAPEUTICS

gilboa-therapeutics-logo

Gilboa Therapeutics a next-generation cancer immunotherapy company focused on the development of novel and transformative cell therapies designed to harness the power of a patient's own immune system to more effective treat a wide range of cancer types, with a mission to dramatically improve patient outcomes and save lives.

#SimilarOrganizations #People #Financial #Website #More

GILBOA THERAPEUTICS

Social Links:

Industry:
Biotechnology

Founded:
2021-01-01

Address:
Rehovot, HaMerkaz, Israel

Country:
Israel

Website Url:
http://www.gilboa.bio

Status:
Active

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business Google GStatic Google Static Content Google Cloud


Similar Organizations

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

harpoon-therapeutics-logo

Harpoon Therapeutics

Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.

metis-therapeutics-logo

METiS Therapeutics

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

rootpath-genomics-logo

RootPath Genomics

RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.


Current Advisors List

not_available_image

Yaron Carmi Co-Founder @ Gilboa Therapeutics
Advisor

Current Employees Featured

not_available_image

Itamar Levy
Itamar Levy COO @ Gilboa Therapeutics
COO

not_available_image

Shahar Dotan
Shahar Dotan R&D Director @ Gilboa Therapeutics
R&D Director

not_available_image

Diana Rasoulouniriana
Diana Rasoulouniriana Senior Scientist @ Gilboa Therapeutics
Senior Scientist

not_available_image

Noam Pilpel
Noam Pilpel CTO @ Gilboa Therapeutics
CTO

not_available_image

Peleg Rider
Peleg Rider VP Immunology @ Gilboa Therapeutics
VP Immunology

not_available_image

Hana Shpilt
Hana Shpilt Scientist @ Gilboa Therapeutics
Scientist

Investors List

nfxcapital_image

NFX

NFX investment in Seed Round - Gilboa Therapeutics

Official Site Inspections

http://www.gilboa.bio

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Gilboa Therapeutics"

Gilboa Therapeutics - Crunchbase Company Profile & Funding

Contact Email [email protected] Gilboa Therapeutics a next-generation cancer immunotherapy company focused on the development of novel and transformative cell therapies designed to โ€ฆSee details»

Gilboa Therapeutics Company Profile 2025: Valuation, โ€ฆ

Gilboa Therapeutics was founded in 2019. Where is Gilboa Therapeutics headquartered? Gilboa Therapeutics is headquartered in Rehovot, Israel. What industry is Gilboa Therapeutics in? Gilboa Therapeuticsโ€™s primary industry is โ€ฆSee details»

Gilboa Therapeutics - BIO International Convention | BIO

Jun 6, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Gilboa โ€ฆSee details»

Gilboa Therapeutics - LinkedIn

Gilboa Therapeutics is a preclinical-stage, cancer immunotherapy company focused on the development of next-generation cell therapies designed to harness the power of a patient's โ€ฆSee details»

Gilboa Therapeutics - Israeli Startup | Startup Nation Finder

Jul 8, 2022 Gilboa Therapeutics Overview Gilboa Therapeutics is a preclinical-stage cancer immunotherapy company with a mission to dramatically improve outcomes and save lives. The โ€ฆSee details»

Gilboa Therapeutics, Inc. - VentureRadar

Vesper Bio Denmark Privately Held Vesper Biotechnology is a preclinical biotech company developing treatments based on Vps10p-protein to target various therapeutic indications. โ€ฆSee details»

Gilboa Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...

Explore Gilboa Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Neoplasms, Technology Platform:T-lymphocyte cell therapy, โ€ฆSee details»

Gilboa Therapeutics - BIO International Convention 2024

Gilboa Therapeutics Gilboa Therapeutics. Biotech or pharma, therapeutic R&D Address Cambridge Massachusetts United States ... BIO DOUBLE HELIX SPONSORS . Thanks to our โ€ฆSee details»

Gilboa Therapeutics to Present at the H. | Gilboa Therapeutics

Jan 6, 2022 Gilboa Therapeutics Inc., a preclinical-stage biopharmaceutical company focused on the discovery and development of next-generation cell therapies, today announced thatโ€™s โ€ฆSee details»

Gilboa Therapeutics to Present at the H.C. Wainwright ... - PRWeb

SAN DIEGO, Jan. 6, 2022 /PRNewswire-PRWeb/ -- Gilboa Therapeutics Inc., a preclinical-stage biopharmaceutical company focused on the discovery and development of next-generation cell โ€ฆSee details»

Gilboa Therapeutics - Next-generation Cell Therapy for the โ€ฆ

Jul 8, 2022 Find out more about Gilboa Therapeutics's founders and team members at Start-Up Nation Finder!See details»

Gilboa Therapeutics - Products, Competitors, Financials, โ€ฆ

Gilboa Therapeutics is a preclinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies. Use the CB Insights Platform to explore โ€ฆSee details»

Gilboa Therapeutics Appoints Barry Labinger as CEO to Develop โ€ฆ

Jun 14, 2022 Gilboa Therapeutics Inc., a preclinical-stage biopharmaceutical company developing a novel cell therapy platform to target solid tumors, today announced the โ€ฆSee details»

NEWS - Gilboa Therapeutics

Gilboa Therapeutics, a preclinical stage biotechnology company, today announced the presentation of pre-clinical data at the annual meeting of the American Association for Cancer โ€ฆSee details»

Gilboa Therapeutics Presents Pre-clinical Data at AACR Supporting ...

Apr 10, 2024 Gilboa Therapeutics, a preclinical stage biotechnology company, today announced the presentation of pre-clinical data at the annual meeting of the American Association for โ€ฆSee details»

SolidT, a platform technology for targeting solid tumors with safer โ€ฆ

Potential. Discuss milestones, potential collaborations, and partnerships. Gilboa Tx is developing an extensive pipeline which include combining SolidT cells with trastuzumab for HER2 โ€ฆSee details»

10 Things You Didnโ€™t Know about David Gilboa - Money Inc

Oct 11, 2021 What do you know about David Gilboa, the co-founder and co-CEO of eyewear company Warby Parker? Lots of people use the company to purchase eyewear, but โ€ฆSee details»

Warby Parker Co-founder, Dave Gilboa: Building a Life and Brand โ€ฆ

Dave Gilboa is the co-founder/CEO of Warby Parker. Growing up in San Diego, the son of two doctors, Gilboa was sure heโ€™d become a doctor, too. But, a random moment where he lost his โ€ฆSee details»

ADAMA Reaches a Milestone With New Active Ingredient Gilboaโ„ข

Dec 6, 2024 โ€œBased on our extensive field trials, Gilboa โ„ข is a major game-changer for cereal farmers in Great Britain, Europe and globally,โ€ says Florian Wagner, EVP Portfolio and โ€ฆSee details»

linkstock.net © 2022. All rights reserved